newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission

MONTREAL, Nov. 18, 2022 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development is providing its